Super-resolution microscopy for immune checkpoint inhibitors diagnostics

NANODIAGNOSTIC aims to translate super-resolution microscopy techniques into clinical tools for cancer diagnostics, enhancing patient stratification for effective immunotherapy.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

In the last decade, super-resolution microscopy techniques have emerged as powerful quantitative tools for biology. They have capabilities to visualize single molecules at the nanoscale, opening the door to study biological processes at a level not accessible before.

Project Overview

In the ERC StG NANOSTORM, we showed the potential of these techniques, providing new fundamental knowledge on the mechanism and design of new targeted therapies. However, some of the methods we developed have the potential to be translated into applied clinical diagnostic tools.

Objectives of NANODIAGNOSTIC

In NANODIAGNOSTIC, we would offer a proof-of-concept of the application of super-resolution microscopy and single-molecule imaging for cancer diagnostics, with a focus on:

  1. Patient stratification for immunotherapy.
  2. Development of new diagnostic methods.

Immunotherapy Context

Novel advances in immunotherapies have brought the development of immune checkpoint inhibitors (ICI) that re-activate the immune system against the tumor. Despite the high success of these therapies, there is one main challenge:

  • They are only effective on a limited portion of patients, and current diagnostic approaches are not capable of stratifying patients successfully.

Potential Impact

NANODIAGNOSTIC will translate advanced optical methods from an academic setting to the clinic and holds great potential to provide new diagnostic methods to improve the outcome of immunotherapy.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-12-2022
Einddatum31-5-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITEIT EINDHOVENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

ERC COG

Nano-assisted digitalizing of cancer phenotyping for immunotherapy

The ImmunoChip project aims to develop a microfluidic device that analyzes cancer-immunity interactions to predict patient responses to immunotherapy, enhancing treatment efficacy and outcomes.

€ 1.993.875
ERC ADG

Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in immunotherapy

The project aims to develop novel Nanobodies as safe and effective modulators of immune checkpoint complexes for cancer and autoimmune diseases, potentially outperforming current therapies.

€ 2.499.674
EIC Accelerator

IOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology.

The project aims to enhance cancer immunotherapy efficacy by developing a validated biomarker assay to predict patient responses, potentially doubling survival rates for lethal tumors.

€ 2.496.112